Home  |    Contact Us   |    Scheduled Procedure Screening Form   |    Saturday Screenings   |    Survey   |    Pay Bill
Dr. Swapnil D. Munsaf, MD
May 2003
Bachelor of Arts, Biology and Psychology
University of Rochester
May 2007           

Doctor of Medicine
University of Rochester

May 2010          

Residency in Internal Medicine
University of Rochester Medical Center

June 2013           
Fellowship in Gastroenterology
State University of New York at Buffalo
June 2014  Advanced Therapeutic Endoscopy Fellowship
University of Massachusetts Memorial Medical Center


Connecticut Medical License: #53046
- Awarded Interventional Endoscopy Course Grants
- University of Rochester Rush Rhees Scholarship
- Rochester Early Medical Scholars Program
- Dean's List all semesters University of Rochester

2013  American Board of Internal Medicine
2010  American Board of Gastroenterology

2013 – Present 

Attending Physician
Department of Gastroenterology
University of Massachusetts Memorial Medical Center
University of Massachusetts - Worcester

2013 – Present  Assistant Professor of Medicine
Department of Medicine, Gastroenterology
University of Massachusetts - Worcester
2013 – Present Assistant Professor of Medicine
University of MA - Worcester


Professional Memberships:
American Society of Gastrointestinal Endoscopy
American Gastroenterology Association
American College of Gastroenterology
American College of Physicians


Munsaf SD; Rani A.
Significance of Incidental Thickening of the Upper GI Tract on Computed Tomography
Presented at DDW National Conference: May 2013.


Munsaf SD; Maliakkal B; Mantry PS.
Renal Impairment in Cirrhotic Patients Undergoing CT Scans with Intravenous Contrast Agents.
Presented at ASLD National Conference: October 2006.

Mantry PS; Munsaf SD.
Rifaximin for the Treatment of Hepatic Encephalopathy.
Transplant Proceedings. December 2010; 42(10):4543-7
Mantry PS; Munsaf SD.
Comparison of Tolerability of Adjunctive Rifaximin Treatment Versus Lactulose Monotherapy for Hepatic Encephalopathy.
Presented at ASLD National Conference: October 2008.
Mantry PS; Munsaf SD.
Analysis of the Effect of Rifaximin Plus Lactulose on Hospitalizations in Patients With End-Stage Liver Disease.
Presented at ASLD National Conference: October 2008.
Mantry PS; Munsaf SD.
Does the Addition of Rifaximin to Lactulose Reduce the Severity of Hepatic Encephalopathy? A Single-Center Experience.
Presented at ASLD National Conference: October 2008.
Nothing found at this website should be construed as medical advice or treatment recommendations by SFGIE. This information is not a substitute for consultation for any symptoms you may have. Note that you should consult your gastroenterologist, colorectal surgeon or family physician for medical advice.
In the case of bad weather the facility will remain open unless the governor shuts the state down or the facility does not have power.
Copyright © 2015 - sfgie.com - All Rights Reserved